Skip to content

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor - The Cog-HF trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030230386
Enrollment
220
Registered
2023-10-07
Start date
2023-10-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

The study will perform a comprehensive disease management program for eligible patients in the intervention arm. This comprehensive disease management program will consist of fluid assessment with poc
dementia, heart failure

Sponsors

Obokata Masaru
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients equal or more than 50 years age 2) Patients with heart failure 3) Patients with a baseline MoCA-J score < 26 (regardless of the cause of dementia) 4) Patients who have given written informed consent to participate in the study

Exclusion criteria

Exclusion criteria: 1) Patients with severe dementia for whom MoCA-J is difficult to perform 2) Patients who require palliative care 3) Patients with comorbidities for which a prognosis of at least 1 year is not expected (other than heart failure) 4) Patients participating in other interventional trials 5) Other patients who are judged by the physician to be inappropriate for inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Change in MoCA-J from baseline to 12 months after intervention

Secondary

MeasureTime frame
Change in Hippocampal Volume from baseline to 12 months after intervention Change in cerebral white matter lesions from baseline to 12 months after intervention Change in cerebral gray matter volume from baseline to 12 Months after intervention Change in KCCQ-12 from baseline to 12 months after intervention Change in NT-proBNP from baseline to 12 months after intervention Change in E/e' from baseline to 12 months after iIntervention Change in left atrial volume from baseline to 12 months after intervention

Contacts

Public ContactMasaru Obokata

Gunma University Hospital

obokata.masaru@gunma-u.ac.jp+81-27-220-8145

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026